Servix ripening.
Conditions
Interventions
Intervention 1: Intervention group: the case group receiving a 1000 mg vaginal EPO capsule produced by Barij Essence Company,. Intervention 2: Control group: and the placebo group receiving a vaginal
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Written informed consent to enter the studyPregnancy over 38 weeks based on the first day of the last menstrual period or ultrasound during the first 3 months of pregnancyNo contraindications for natural childbirthSuitability for natural childbirthcephalic presentation of the baby
Exclusion criteria
Exclusion criteria: Chronic and systemic diseases such as diabetes and heart disease mproper fetal position such as breeching, Existence of fetal disorders such as hydrops and hydrocephalus Women with high-risk pregnancies (e.g. preeclampsia) Contraindications to evening primrose oil (people with a history of seizures, people with schizophrenia receiving phenothiazines, bleeding disorders, or medications that slow blood clotting) Drop in fetal heart rate during the studyStop fetal descent Bleeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Servix ripening. Timepoint: First visit then weakly. Method of measurement: Question. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmadli zahra
Shahid Beheshti University of Medical Sciences
Outcome results
None listed